Published on
May 3, 2023
- 12:23 GMT
Akaal Pharma Pty Ltd has received approval for a Phase-2 clinical trial involving patients with atopic dermatitis
AUSTRALIA, May 3, 2023 /EINPresswire.com/ -- Akaal Pharma Pty Ltd has received approval for a Phase-2 clinical trial involving patients with atopic dermatitis. Akaal Pharma Pty Limited (Akaal) today announced that it has received regulatory approval …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
